🇺🇸 FDA
Patent

US 10456439

NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation

granted A61KA61K38/046A61K9/0019

Quick answer

US patent 10456439 (NK3 agonist for use in the treatment of a patient suffering from atrial arrhythmia or fibrillation) held by ACADEMISCH MEDISCH CENTRUM expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM
Grant date
Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/046, A61K9/0019, A61K9/0053, A61P